Viatris Names Interim CFO as Executive Transition Begins
Event summary
- Theodora 'Doretta' Mistras, CFO of Viatris, departs for a new opportunity effective May 22, 2026.
- Paul Campbell, current Chief Accounting Officer, named interim CFO starting May 8, 2026.
- Campbell has over two decades of experience, including roles at Mylan and Deloitte & Touche.
- Viatris to release Q1 2026 financial results on May 7, 2026.
The big picture
Viatris's CFO transition comes as the company positions itself for sustainable growth, a critical phase for a global healthcare player navigating competitive pressures and regulatory dynamics. The move underscores the importance of financial governance in maintaining operational discipline during strategic shifts. With a portfolio spanning generics, established brands, and innovative medicines, Viatris's ability to attract and retain key financial leadership will be pivotal in executing its long-term vision.
What we're watching
- Leadership Continuity
- How Paul Campbell's interim role will impact Viatris's financial strategy and operational discipline during the transition.
- Strategic Growth
- Whether Viatris can maintain its focus on sustainable growth amid executive changes.
- Financial Performance
- The pace at which Viatris can achieve its long-term financial goals under new leadership.
Related topics